We studied the effect of homologous challenge of EU subtype 1 and 3 PRRSV.
Subtype 3 induced stronger inflammatory responses than 1 after primo infection.
There were no differences between subtype 1 and 3 in protection after challenge.
Adaptive responses were comparable between subtype 1 and 3 infection.
Differences in in-vitro heterologous responses require further research.